The Hydration Pharmaceuticals Company (ASX:HPC) — Material Events
ASX:HPC · 7 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Hydralyte USA Raises A$392k, Revamps Board and Cuts Costs to Boost US GrowthMedium
Hydralyte USA raises A$392k, appoints new board members, and plans cost cuts
15 June 2026
·Capital Raising and Board Changes
·85
HPC seeks A$1.43 million to fund working capital after US business turns profitableHigh
Hydration Pharmaceuticals launches A$1.435 million entitlement offer with free options
23 Oct 2026
·Capital Raising
·82
Hydralyte cuts EBITDA loss 75% as US business turns monthly profitableMedium
Hydralyte cuts two-month EBITDA loss 75% as US business reaches maiden monthly profit
29 Sept 2026
·Trading Update
·78
Hydration Pharmaceuticals Reports $2.86M Loss, Eyes Strategic Moves Amid Trading HaltMedium
Hydration Pharmaceuticals relodges FY25 Annual Report amid trading halt; reports $2.86M loss and ongoing cost-cutting
1 May 2026
·Annual Report Relodgement
·70
Hydralyte USA Cuts Costs by US$25K Monthly, Resolves Supply ConstraintsMedium
Hydralyte USA cuts costs by US$25K/month, resolves supply issues, replenishes inventory
17 Feb 2026
·Company Announcement
·70
HPC Returns to ASX Trading After Reporting $2.86M LossMedium
HPC Reinstated to ASX Quotation from 4 May 2026
4 May 2026
·Reinstatement to Quotation
·50
No articles in this tier for the last 12 months.
Market Mentions
4
- appeared in market wrap coverage
These are market wrap articles where The Hydration Pharmaceuticals Company (ASX:HPC) was mentioned. They reflect broader market coverage, not company-specific announcements.
Market Wrap - Week 25 (15 June -> 19 June) 2026
20 June 2026
Healthcare Wrap - Week 19 (4 May -> 8 May) 2026
9 May 2026
Healthcare Wrap - Week 18 (27 Apr -> 1 May) 2026
2 May 2026
Healthcare Wrap - Week 8 (16 Feb -> 20 Feb) 2026
21 Feb 2026